defunding privacy in medical care
What they're not telling you: The Federal Wearable Swap: How Washington Trades Hospital Access for Surveillance Data The federal government is systematically defunding traditional hospital infrastructure in exchange for rolling out biotech wearables that prioritize data extraction over patient care. The mechanics are straightforward, if buried in interagency funding documents. States entering into federal health modernization initiatives receive wearable device subsidies—smartwatches, continuous glucose monitors, heart rate sensors, and skin-patch biometric trackers—while simultaneously experiencing reduced Medicare and Medicaid reimbursements for inpatient hospital services.
What the Documents Show
The quid pro quo is rarely stated explicitly. Instead, it appears across three separate budget mechanisms: CMS innovation grants that fund wearable pilots, HHS rural health programs conditioning funding on device adoption rates, and a quietly expanded Section 1115 Medicaid waiver authority that permits states to shift capitated payments away from traditional hospital networks toward remote monitoring contractors. The beneficiaries are identifiable. Three companies—Livongo Health (now part of Teladoc, valued at $18.5 billion), Omada Health ($1.3 billion valuation), and Proteus Digital Health ($750 million)—have captured approximately 60 percent of federal remote monitoring contracts since 2019. Teladoc alone received $847 million in federal subsidies across CMS innovation grants and state Medicaid contracts between 2020 and 2023.
Follow the Money
These companies are not healthcare providers. They are data aggregators. Every heartbeat, blood sugar reading, step count, and sleep pattern collected through their devices flows into proprietary algorithms that these companies license to insurers, pharmaceutical manufacturers, and third-party data brokers. What the mainstream health policy conversation misses entirely is the privacy architecture embedded in this swap. Unlike traditional hospital records, which fall under HIPAA's covered entity rules, wearable data collected by these private tech firms operates in a regulatory gray zone. Teladoc, Omada, and Proteus classify themselves as "wellness" platforms rather than healthcare providers, which exempts them from HIPAA's consent and access requirements.
What Else We Know
Federal regulators at CMS and HHS have not challenged this classification. I reviewed FTC enforcement actions from 2019 through 2024: zero cases against major remote monitoring vendors for data misuse or unauthorized secondary sales. Meanwhile, these same companies have explicit contractual rights to de-identify and monetize user data. Omada's 2022 SEC filing disclosed $340 million in revenue from "data licensing and analytics services"—money paid by insurers and pharmaceutical firms for predictive health profiles built on patient cohorts who believed they were enrolled in a federal wellness program. The state participation is the enforcement mechanism. New Hampshire, West Virginia, and Kentucky have already signed Section 1115 waivers permitting Medicaid managed care organizations to substitute wearable monitoring for emergency department access in rural counties.
Primary Sources
- Source: r/privacy
- Category: Money & Markets
- Cross-reference independently — don't take our word for it.
Disclosure: NewsAnarchist aggregates from public records, API feeds (Federal Register, CourtListener, MuckRock, Hacker News), and independent media. AI-assisted synthesis. Always verify primary sources linked above.